«A reduced fixed dose of Tocilizumab 200 mg compared to 400 mg in patients with severe COVID-19 disease», OH&RM, bd. 4, nr. 4, s. 19–26, sep. 2023, doi: 10.38045/ohrm.2023.4.02.